Estimating creatinine clearance in morbidity obese patients

Area of Science:

• Nephrology
• Pharmacokinetics
• Obesity Medicine

Background:

• Accurate estimation of creatinine clearance (Clcr) is crucial for drug dosing and assessing kidney function.
• Morbidly obese patients present unique physiological challenges that may affect the accuracy of standard Clcr estimation formulas.
• Existing Clcr estimation methods often rely on variables that may not be representative in individuals with extreme obesity.

Purpose of the Study:

• To evaluate the accuracy of five different creatinine clearance (Clcr) estimation methods in morbidly obese patients.
• To compare estimated Clcr values with measured 24-hour urinary Clcr in a cohort of morbidly obese individuals.
• To determine if methods incorporating total body weight (TBW) or ideal body weight (IBW) improve accuracy.

Main Methods:

• A comparative study involving 43 morbidly obese patients (12 men, 31 women) with measured 24-hour urinary Clcr.
• Evaluation of five Clcr estimation methods utilizing factors such as weight (TBW and IBW), age, sex, and serum creatinine.
• One method involved a nomogram, while others incorporated weight as a variable.

Main Results:

• Measured Clcr averaged 105.7 ml/min/1.73 sq m body surface area.
• Methods using ideal body weight (IBW) significantly underestimated Clcr.
• Methods using total body weight (TBW) significantly overestimated Clcr.
• Two methods not including body weight showed better accuracy but still had significant differences from measured Clcr.

Conclusions:

• None of the evaluated creatinine clearance (Clcr) estimation methods are accurate for morbidly obese patients.
• Both IBW- and TBW-based estimations demonstrate significant inaccuracies.
• Further research is needed to develop reliable Clcr estimation formulas for the morbidly obese population.